297 related articles for article (PubMed ID: 32125009)
1. Clinical features, complications, and outcomes of exogenous and endogenous catecholamine-triggered Takotsubo syndrome: A systematic review and meta-analysis of 156 published cases.
Y-Hassan S; Falhammar H
Clin Cardiol; 2020 May; 43(5):459-467. PubMed ID: 32125009
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome.
Y-Hassan S; Falhammar H
Endocrine; 2019 Sep; 65(3):483-493. PubMed ID: 31399912
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcome of epinephrine-induced takotsubo syndrome: Analysis of 33 published cases.
Y-Hassan S
Cardiovasc Revasc Med; 2016; 17(7):450-455. PubMed ID: 27499059
[TBL] [Abstract][Full Text] [Related]
4. Serotonin norepinephrine re-uptake inhibitor (SNRI)-, selective norepinephrine reuptake inhibitor (S-NRI)-, and exogenously administered norepinephrine-induced takotsubo syndrome: Analysis of published cases.
Y-Hassan S
Int J Cardiol; 2017 Mar; 231():228-233. PubMed ID: 28073659
[TBL] [Abstract][Full Text] [Related]
5. Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma.
Zhou J; Xuan H; Miao Y; Hu J; Dai Y
BMC Cardiovasc Disord; 2021 Apr; 21(1):203. PubMed ID: 33882857
[TBL] [Abstract][Full Text] [Related]
6. Plasma Epinephrine Level and its Causal Link to Takotsubo Syndrome Revisited: Critical Review with a Diverse Conclusion.
Y-Hassan S
Cardiovasc Revasc Med; 2019 Oct; 20(10):907-914. PubMed ID: 30446399
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features and Outcome of Pheochromocytoma-Induced Takotsubo Syndrome: Analysis of 80 Published Cases.
Y-Hassan S
Am J Cardiol; 2016 Jun; 117(11):1836-44. PubMed ID: 27103159
[TBL] [Abstract][Full Text] [Related]
8. A single pathophysiological pathway in Takotsubo cardiomyopathy: Catecholaminergic stress.
Coupez E; Eschalier R; Pereira B; Pierrard R; Souteyrand G; Clerfond G; Citron B; Lusson JR; Mansencal N; Motreff P
Arch Cardiovasc Dis; 2014 Apr; 107(4):245-52. PubMed ID: 24796853
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of acute takotsubo syndrome and acute coronary syndrome.
Sharkey SW; Kalra A; Henry TD; Smith TD; Pink VR; Lesser JR; Garberich RF; Maron MS; Maron BJ
Catheter Cardiovasc Interv; 2020 Oct; 96(4):825-829. PubMed ID: 31696663
[TBL] [Abstract][Full Text] [Related]
10. Contemporary review on the pathogenesis of takotsubo syndrome: The heart shedding tears: Norepinephrine churn and foam at the cardiac sympathetic nerve terminals.
Y-Hassan S; De Palma R
Int J Cardiol; 2017 Feb; 228():528-536. PubMed ID: 27875730
[TBL] [Abstract][Full Text] [Related]
11. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma.
Giavarini A; Chedid A; Bobrie G; Plouin PF; Hagège A; Amar L
Heart; 2013 Oct; 99(19):1438-44. PubMed ID: 23837998
[TBL] [Abstract][Full Text] [Related]
12. Coronary artery myointimal dysplasia in patients with pheochromocytoma-possible causal relationship: pathophysiology and clinical implication with reference to Takotsubo cardiomyopathy and spontaneous coronary dissection.
Chow LTC; Chow MBCY
Cardiovasc Pathol; 2018; 37():45-53. PubMed ID: 30342321
[TBL] [Abstract][Full Text] [Related]
13. Plasma catecholamine levels in patients with takotsubo syndrome: Implications for the pathogenesis of the disease.
Y-Hassan S; Henareh L
Int J Cardiol; 2015 Feb; 181():35-8. PubMed ID: 25481310
[No Abstract] [Full Text] [Related]
14. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience.
Schwarz K; Ahearn T; Srinivasan J; Neil CJ; Scally C; Rudd A; Jagpal B; Frenneaux MP; Pislaru C; Horowitz JD; Dawson DK
J Am Soc Echocardiogr; 2017 Aug; 30(8):745-755. PubMed ID: 28599831
[TBL] [Abstract][Full Text] [Related]
15. Comparison of electrographic changes, clinical features and outcomes in different variants of Takotsubo syndrome.
Looi JL; Voss J; Gilmore J; Heaven D; Lee M; Kerr AJ
Int J Cardiol; 2024 Jul; 406():132072. PubMed ID: 38643795
[TBL] [Abstract][Full Text] [Related]
16. Acute cardiac sympathetic disruption in the pathogenesis of the takotsubo syndrome: a systematic review of the literature to date.
Y-Hassan S
Cardiovasc Revasc Med; 2014 Jan; 15(1):35-42. PubMed ID: 24140050
[TBL] [Abstract][Full Text] [Related]
17. Incremental "Therapeutic" Myocardial Exposure to Catecholamines: Incidence and Impact in Takotsubo Syndrome.
Ong GJ; Nguyen TH; Stansborough J; Surikow SY; Horowitz JD
Cardiovasc Drugs Ther; 2020 Feb; 34(1):95-100. PubMed ID: 32076930
[TBL] [Abstract][Full Text] [Related]
18. Reversible cardiogenic shock due to catecholamine-induced cardiomyopathy: a variant of takotsubo?
Law C; Khaliq A; Guglin M
Am J Emerg Med; 2013 Nov; 31(11):1621.e1-3. PubMed ID: 23810075
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular contraction patterns in patients with suspected acute coronary syndrome and normal coronary angiograms: a new look at the takotsubo syndrome.
Paixao AR; Balaji N; Ryzhikov A; Ghafourian K; Collins S; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R; Lindsay J
Clin Cardiol; 2011 Jan; 34(1):45-50. PubMed ID: 21259278
[TBL] [Abstract][Full Text] [Related]
20. Takotsubo cardiomyopathy systematic review: Pathophysiologic process, clinical presentation and diagnostic approach to Takotsubo cardiomyopathy.
Ono R; Falcão LM
Int J Cardiol; 2016 Apr; 209():196-205. PubMed ID: 26896623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
